TREATMENT OF MULTIPLE SCLEROSIS WITH LAQUINIMOD

Lakvinimod za upotrebu u smanjenju stope relapsa i(li) smanjenju akumulacije fizičkog invaliditeta koji se procenjuju pomoću vremena koje protekne do potvrđenog napretka bolesti kod pacijenata - ljudi koji pate od multiple skleroze sa relapsima i remisijama, naznačen time što se navedeni lakvinimod...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KOFLER, DINA, TARCIC, NORA, BAR-ZOHAR, DAN
Format:	Patent
Sprache:	eng ; srp
Schlagworte:	AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES FISHING FORESTRY HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE PEST REPELLANTS OR ATTRACTANTS PLANT GROWTH REGULATORS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TRAPPING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Lakvinimod za upotrebu u smanjenju stope relapsa i(li) smanjenju akumulacije fizičkog invaliditeta koji se procenjuju pomoću vremena koje protekne do potvrđenog napretka bolesti kod pacijenata - ljudi koji pate od multiple skleroze sa relapsima i remisijama, naznačen time što se navedeni lakvinimod priprema za primenu u doznom režimu od 0,6 mg lakvinimoda dnevno.Prijava sadrži još 13 patentnih zahteva. The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient.